Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A tyrosine kinase inhibitor (TKI) is a pharmaceutical agent that blocks the activity of enzymes known as tyrosine kinases. These enzymes play a crucial role in various cellular processes, including cell signaling, growth, and division. In certain cancers, tyrosine kinases are overactive or present at abnormally high levels, contributing to uncontrolled cell proliferation. By inhibiting these enzymes, TKIs can help prevent cancer cells from growing and dividing.
Inhibition of tyrosine kinase phosphorylation by binding to the ATP-binding site or allosteric sites of the kinase domain.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine Kinase Inhibitor.